CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 40 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $63 | +250.0% | 143,265 | +77.7% | 0.01% | +250.0% |
| Q4 2022 | $18 | -99.9% | 80,619 | +117.4% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -77.9% | 37,077 | -68.9% | 0.00% | -85.7% |
| Q4 2021 | $136,000 | +177.6% | 119,238 | +506.7% | 0.01% | +250.0% |
| Q3 2021 | $49,000 | -83.4% | 19,653 | -68.3% | 0.00% | -87.5% |
| Q4 2020 | $295,000 | +9.3% | 62,001 | -25.3% | 0.03% | +3.2% |
| Q2 2020 | $270,000 | +196.7% | 82,976 | +645.3% | 0.03% | +520.0% |
| Q4 2017 | $91,000 | – | 11,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
| Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
| GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
| SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
| Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
| Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
| Virtu Financial LLC | 19,653 | $49,000 | 0.00% |